I have been told by people who know such things that the Dems are looking at ways to allow Medicare to negotiate prices with the drug industry, without offering its own plan, that actually would be meaningful. For example, it could negotiate a set of prices that would apply to all the insurance plans included under Part D. This seems unduly complex, but it could lead to lower drug prices.
Whether they end up going this route and designing something that actually reduces drug prices, or whether they do something that is purely symbolic, remains to be seen. The moral of the story is that everything will depend on the details of how any reform measure is structured. If the public is not informed of these details, it will not be able to distinguish between a substantive measure and a purely symbolic one until it is time to pay the bills.
If you enjoyed this article, please consider making a tax-deductible donation today. For over 30 years, The American Prospect has delivered independent reporting that exposes corporate power, investigates political corruption, and analyzes threats to our democracy. Unlike many media outlets, we’re not owned by billionaires or corporations—we’re powered by readers like you.
Today’s independent journalism faces unprecedented challenges. Your support makes our reporting possible and keeps our work free and accessible to all. Whether it’s $5 or $50, every contribution helps sustain our nonprofit newsroom.
Join our community of supporters and make a donation today to help keep independent journalism thriving.
Copyright 2025 | The American Prospect, Inc. | All Rights Reserved
